SPONSOR

Nantes University Hospital

Total Trials

Recruiting

Phases

Phase 3, Phase 2

Conditions studied: Hospital Acquired Pneumonia Asthma Transthyretin Cardiac Amyloidosis Acne Frontotemporal Lobar Degeneration Adverse Event Sepsis Septic Shock Development and Health Metabolism Changes

Nantes University Hospital is a clinical research sponsor with 24 registered studies on ClinicalTrials.gov, of which 24 are actively recruiting participants. Research covers conditions including Hospital Acquired Pneumonia, Asthma, Transthyretin Cardiac Amyloidosis, Acne.

The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Nantes University Hospital

How many clinical trials has Nantes University Hospital sponsored?

ClinicalMetric currently tracks 24 clinical trials sponsored by Nantes University Hospital, of which 24 are actively recruiting participants. These trials cover conditions including Hospital Acquired Pneumonia, Asthma, Transthyretin Cardiac Amyloidosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Nantes University Hospital research focus on?

Nantes University Hospital clinical trials span Hospital Acquired Pneumonia, Asthma, Transthyretin Cardiac Amyloidosis, Acne, Frontotemporal Lobar Degeneration, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Nantes University Hospital clinical trial?

To participate in a Nantes University Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nantes University Hospital trials with current recruitment status updated daily.

Nantes University Hospital

Frequently Asked Questions — Nantes University Hospital

Clinical Trials by Nantes University Hospital

Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype

Study of the Impact of Exposure to Outdoor and Indoor Pollutants in Patients With Asthma

Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis

Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital

The Skin as a Window to the Central Nervous System in Frontotempolar Lombar Degeneration

Patient Safety Incidents in Coordinated Primary Care Teams: a Multi-method Study

Evaluation of Blood Protein O-GlcNAcylation Levels in Children

Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease

Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders

Prospective Multicenter Randomized and Controlled Study Evaluating the Benefit of Early Pulmonary Vein Isolation Compared to Usual Treatment in Patients Aged Over 75 Years and Presenting With Atrial Fibrillation

Cardiopediatric Home Monitoring Tool

Identifying Electrocardiographic Markers to Determine Eligibility for the Implantation of a Subcutaneous Defibrillator.

Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity

Belatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft Dysfunction

Non Traumatic Neuro-Vascular Diseases Critical Complications : a Prospective Cohort Study

Advanced Practice Nurses for Fall Incidence PrevenTion in Very Old Robust Adults

Post Traumatic Critical Complications: a Prospective Cohort Study (ATLANREA)

Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)

Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".

Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy

Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room

Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia

The Enteric Nervous System in Spinal Cord Injury: Study of the Enteric Nervous System and the Intestinal Epithelial Barrier Via Colonic Biopsies in Spinal Cord Injury Patients

Building of a Diagnostic/Prognostic Database for Human ERG Variant Effects